Chongqing Pharscin Pharmaceutical (002907.SZ) received the approval notice for the supplementary drug application of Jian'er Xiaoshi Oral Liquid.
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for the company's product Jian'er Xiaoshi Oral Liquid, which will change the safety and other content in the drug instructions of Jian'er Xiaoshi Oral Liquid.
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for the company's product Jian'er Xiaoshi Oral Liquid, which will change the safety and other content in the drug instructions of Jian'er Xiaoshi Oral Liquid.
Obtaining the "Drug Supplementary Application Approval Notice" this time indicates that the company has further improved the content of safety information in the drug instructions, which is conducive to the promotion of the product in the terminal market.
Related Articles
Huasu Holdings (000509.SZ) shareholder Xintong Wanhua plans to reduce its shareholding by no more than 3%.
HOSPITAL CORP (03869): Cao Yonggang re-designated as Executive Director
JNCEC (00579): Chen Dayu re-elected as Chairman of the Board
Huasu Holdings (000509.SZ) shareholder Xintong Wanhua plans to reduce its shareholding by no more than 3%.
HOSPITAL CORP (03869): Cao Yonggang re-designated as Executive Director
JNCEC (00579): Chen Dayu re-elected as Chairman of the Board
